Validating fatty acid binding protein 3 as a diagnostic and prognostic biomarker for peripheral arterial disease: A three-year prospective follow-up study.
- DOI
- 10.1016/j.eclinm.2022.101766
- Published
- 2023 Jan
- Container
- EClinicalMedicine
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.eclinm.2022.101766,
title = {Validating fatty acid binding protein 3 as a diagnostic and prognostic biomarker for peripheral arterial disease: A three-year prospective follow-up study.},
author = {Zamzam A and Syed MH and Rotstein OD and Eikelboom J and Klein DJ and Singh KK and Abdin R and Qadura M},
year = {2023},
journal = {EClinicalMedicine},
doi = {10.1016/j.eclinm.2022.101766},
url = {https://doi.org/10.1016/j.eclinm.2022.101766}
}RIS
TY - JOUR TI - Validating fatty acid binding protein 3 as a diagnostic and prognostic biomarker for peripheral arterial disease: A three-year prospective follow-up study. AU - Zamzam A AU - Syed MH AU - Rotstein OD AU - Eikelboom J AU - Klein DJ AU - Singh KK AU - Abdin R AU - Qadura M PY - 2023 JO - EClinicalMedicine DO - 10.1016/j.eclinm.2022.101766 UR - https://doi.org/10.1016/j.eclinm.2022.101766 ER -
APA
A, Z., MH, S., OD, R., J, E., DJ, K., KK, S., R, A., & M, Q. (2023). Validating fatty acid binding protein 3 as a diagnostic and prognostic biomarker for peripheral arterial disease: A three-year prospective follow-up study.. EClinicalMedicine. https://doi.org/10.1016/j.eclinm.2022.101766
Source records
- pubmed · retrieved 2026-09-26T06:49:18.285Z